Know CPT's assay/stain distinction to pick the right code. The adage to "always report the most specific CPT code" could ambush your estrogen receptor (ER) and progesterone receptor (PR) coding for breast cases. Let our experts help you sort out the difference between specific analyte and specific method to make sure you choose the right code -- every time. 1. Reserve 84233 and 84234 for Assays If you're looking for specific codes when a surgical pathology report references estrogen and/or progesterone receptor testing, you can't miss 84233 (Receptor assay; estrogen) and 84234 (... progesterone). But are those always the right choice? "The 84233 and 84234 definitions create a dilemma for coders reporting ER/PR tests," asserts Dennis Padget, MBA, CPA, FHFMA, president of DLPadget Enterprises Inc. and publisher of the Pathology Service Coding Handbook, in The Villages, Fla. "The question is whether you must report 84233/84234 because the definitions specify ER/PR, or if you can instead report a generic immunohistochemistry code such as 88342 (Immunohistochemistry, [including tissue immunoperoxidase], each antibody) for certain ER/PR testing." "Assay" resolves quandary: "Codes 84233 and 84234 describe laboratory tests for estrogen and progesterone receptors that use a biochemical ligand-binding assay method, such as dextran-coated charcoal assay," Padget says. But most labs evaluate ER/PR using immunohistochemistry, because clinical studies have consistently shown the superiority of immunohistochemistry over biochemical assay methods for ER/PR testing. Bottom line: 2. Be on the Lookout for Immunohistochemistry When the lab method involves immunohistochemistry (IHC) for tissue specimens, such as evaluating breast tumors for ER and PR status, you should look to the following codes to describe the service: "Even though these code definitions are 'generic' in the sense that they don't specifically identify estrogen or progesterone receptors, you should use them for an ER or PR (or any other) immunohistochemistry antibody stain," Padget says. 3. Distinguish Qualitative/Quantitative Codes Selecting among 88342, 88360, or 88361 requires knowing whether the immunohistochemistry analysis is qualitative or quantitative (including semiquantitative), and whether quantification uses computer-assisted technology or "manual" counting, including visual approximation. "You might use any of these three codes for ER, PR, Her- 2/neu, Ki-67, or any of several other IHC analyses," Padget says. For instance, an estrogen receptor immunostain might be qualitative (88342), quantified by a person counting or visually approximating stained cells in certain areas of the slide (88360), or quantified using an automated computerized system (88361). 4. Count Antibodies You should report one unit of the appropriate code for each antibody stain, regardless of which antibody you're coding. For instance: If you don't know whether the immunohistochemistry evaluation is qualitative or quantitative/semi-quantitative (not to mention manual or computer assisted for the latter), you can't select the proper code. Assuming that all three antibodies in the preceding example involve manual quantification, you should code the case as 88360 x 3. Count specimens: Although "per stain per specimen" used to be the final word on the matter, pathologists may have new opportunities for special stains, thanks to a CMS policy change. Read all about it in "IHS Stain Unit Change Could Benefit Your Bottom Line," on page 66.